BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2707630)

  • 1. Acid perfusion test: does it have a role in the assessment of non cardiac chest pain?
    Hewson EG; Sinclair JW; Dalton CB; Wu WC; Castell DO; Richter JE
    Gut; 1989 Mar; 30(3):305-10. PubMed ID: 2707630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease.
    Howard PJ; Maher L; Pryde A; Heading RC
    Gut; 1991 Feb; 32(2):128-32. PubMed ID: 1864528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring.
    Pandak WM; Arezo S; Everett S; Jesse R; DeCosta G; Crofts T; Gennings C; Siuta M; Zfass A
    J Clin Gastroenterol; 2002 Oct; 35(4):307-14. PubMed ID: 12352293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain.
    Hewson EG; Sinclair JW; Dalton CB; Richter JE
    Am J Med; 1991 May; 90(5):576-83. PubMed ID: 2029015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid perfusion test and 24-hour esophageal pH monitoring with symptom index. Comparison of tests for esophageal acid sensitivity.
    Richter JE; Hewson EG; Sinclair JW; Dalton CB
    Dig Dis Sci; 1991 May; 36(5):565-71. PubMed ID: 2022156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.
    Dekel R; Martinez-Hawthorne SD; Guillen RJ; Fass R
    J Clin Gastroenterol; 2004 Jan; 38(1):24-9. PubMed ID: 14679323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
    Kahrilas PJ; Hughes N; Howden CW
    Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
    Monés J
    Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease.
    Fass R; Fennerty MB; Johnson C; Camargo L; Sampliner RE
    J Clin Gastroenterol; 1999 Jan; 28(1):36-9. PubMed ID: 9916663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Causes of non-cardiac chest pain: multidisciplinary perspective].
    Ortiz-Olvera NX; González-Martínez M; Ruiz-Flores LG; Blancas-Valencia JM; Morán-Villota S; Dehesa-Violante M
    Rev Gastroenterol Mex; 2007; 72(2):92-9. PubMed ID: 17966367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cardiac chest pain: an update.
    Fass R; Dickman R
    Neurogastroenterol Motil; 2006 Jun; 18(6):408-17. PubMed ID: 16700719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin.
    Ghillebert G; Janssens J; Vantrappen G; Nevens F; Piessens J
    Gut; 1990 Jul; 31(7):738-44. PubMed ID: 2370009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain.
    Wong WM; Lai KC; Lau CP; Hu WH; Chen WH; Wong BC; Hui WM; Wong YH; Xia HH; Lam SK
    Aliment Pharmacol Ther; 2002 Mar; 16(3):465-71. PubMed ID: 11876699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical assessment and health-related quality of life in patients with non-cardiac chest pain.
    Ortiz-Garrido O; Ortiz-Olvera NX; González-Martínez M; Morán-Villota S; Vargas-López G; Dehesa-Violante M; Ruiz-de León A
    Rev Gastroenterol Mex; 2015; 80(2):121-9. PubMed ID: 26148745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
    McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain.
    Singh S; Richter JE; Bradley LA; Haile JM
    Dig Dis Sci; 1993 Aug; 38(8):1402-8. PubMed ID: 8344094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of gastro-oesophageal reflux disease in elderly people.
    Räihä I; Hietanen E; Sourander L
    Age Ageing; 1991 Sep; 20(5):365-70. PubMed ID: 1755393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].
    Huamán JW; Aliaga V; Domenech G; Videla S; Saperas E
    Gastroenterol Hepatol; 2014 Oct; 37(8):452-61. PubMed ID: 24725608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.